Aflibercept 8 mg for Diabetic Macular Edema: 2-Year Results of the Phase 2/3 PHOTON Trial

Related

• 

  Expert Panel: Socioeconomics

  Linda A. Lam, MD, MBA, FASRS

  Ella H Leung, MD

  Mohsin H. Ali, MD

  Hasenin Al-khersan, MD

  Miguel A. Busquets, MD, FACS

  Annual Meeting Talks

  2024

• 

  A Randomized Trial of Intravitreous Anti-VEGF for Prevention of Vision Threatening Complications of Diabetic Retinopathy (Protocol W)

  Raj K. Maturi, MD

  Updates from the Field

  2021

• 

  Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of DR Worsening Over Time: Results of DRCR Retina Network Protocol AA

  Dennis M. Marcus, MD

  Annual Meeting Talks

  2022